RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3'-leader region of genomic RNA.
Linjin FanYulong WangHongxin HuangZequn WangChudan LiangXiaofeng YangPengfei YeJingyan LinWendi ShiYuandong ZhouHuijun YanZhenyu LongZhongyi WangLinna LiuJun QianPublished in: Emerging microbes & infections (2024)
Ebola virus (EBOV) belongs to Filoviridae family possessing single-stranded negative-sense RNA genome, which is a serious threat to human health. Nowadays, no therapeutics have been proven to be successful in efficiently decreasing the mortality rate. RNA binding proteins (RBPs) are reported to participate in maintaining cell integrity and regulation of viral replication. However, little is known about whether and how RBPs participate in regulating the life cycle of EBOV. In our study, we found that RNA binding motif protein 4 (RBM4) inhibited the replication of EBOV in HEK293T and Huh-7 cells by suppressing viral mRNA production. Such inhibition resulted from the direct interaction between the RRM1 domain of RBM4 and the "CU" enrichment elements located in the PE1 and TSS of the 3'-leader region within the viral genome. Simultaneously, RBM4 could upregulate the expression of some cytokines involved in the host innate immune responses to synergistically exert its antiviral function. The findings therefore suggest that RBM4 might serve as a novel target of anti-EBOV strategy.
Keyphrases
- immune response
- binding protein
- human health
- sars cov
- nucleic acid
- risk assessment
- life cycle
- poor prognosis
- cardiovascular disease
- cardiovascular events
- induced apoptosis
- dendritic cells
- climate change
- genome wide
- cell proliferation
- dna methylation
- coronary artery disease
- toll like receptor
- cell therapy
- long non coding rna
- endoplasmic reticulum stress
- transcription factor
- pi k akt